Rosuvastatin Completed Phase 1 Trials for Diabetes Mellitus (DM) / Healthy Volunteers Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT03339752A Study in Healthy Male Subjects to Investigate Whether Administration of ACT-541468 Can Affect the Fate in the Body (Amount and Time of Presence in the Blood) of Rosuvastatin
NCT02962323Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Rosuvastatin Calcium Tablets Under Fed Conditions
NCT02962310Bio Equivalence Study of Torrent Pharmaceutical Ltd's Rosuvastatin Calcium Tablets Under Fasting Condition.
NCT01183585A Study of RO4917838 With Rosuvastatin in Healthy Volunteers
NCT03806101Study of PF-04965842 Effect on Rosuvastatin Pharmacokinetics in Healthy Participants
NCT02854527Transporter Cocktail Mutual Interaction
NCT03010475A Trial Investigating the Effect of Oral Semaglutide on the Pharmacokinetics of Furosemide and Rosuvastatin in Healthy Subjects
NCT02685462Pharmacokinetic and Safety Study of Cenicriviroc and HMG-CoA Reductase Inhibitors, Caffeine and Digoxin
NCT02300363DDI Study With Multiple-dose LX4211 and Single Dose Rosuvastatin
NCT02289430to Investigate the Pharmacokinetic Interactions and Safety Between Rosuvastatin and Ezetimibe in Healthy Male Volunteers
NCT02231931Drug-drug Interaction Between Digoxin, Furosemide, Metformin, and Rosuvastatin
NCT02079506Pharmacokinetic Drug Interaction Between Candesartan and Rosuvastatin
NCT02127320Investigating the Pharmacokinetic Drug Interactions Between Rosuvastatin and Ezetimibe
NCT03216304Safinamide Steady State Interaction With Rosuvastatin
NCT02707224Clinical Trial to Compare the Pharmacokinetics of DP-R208
NCT02709187DP-R208 Pharmacokinetic Study
NCT02611518A Pharmacokinetic Interaction Study Between JNJ-54861911 and Transporter Substrates Rosuvastatin and Metformin in Healthy Participants
NCT02574845DDI (Effect of Metformin and Furosemide on Rosuvastatin PK)
NCT02542969Drug Interaction Study of MGL-3196 With Rosuvastatin and Simvastatin
NCT00826358Comparison of the Bioavailability of Fenofibric Acid and Rosuvastatin From 5/45 mg Strength of ABT-143 Relative to That From the Coadministration of ABT-335 (Fenofibric Acid) 45 mg and Rosuvastatin Calcium 5 mg
NCT00808678Comparison of the Bioavailability of Fenofibric Acid and Rosuvastatin From ABT-143 Relative to That From the Coadministration of ABT-335 (Fenofibric Acid) and Rosuvastatin Calcium
NCT00487136Interaction Between ABT-335, Rosuvastatin and Warfarin
NCT01548157Clinical Trial to Evaluate the Effect on the Pharmacokinetic Characteristics of HCP1007 Capsule
NCT01831479Investigation of Pharmacokinetic Interaction Between Rosuvastatin and Olmesartan in Healthy Male Volunteers
NCT01823133Study for Investigate the Pharmacokinetic Drug Interactions Between Gemigliptin and Rosuvastatin
NCT01795937Investigation of Interactions Between Faldaprevir, Itraconazole, Atorvastatin and Rosuvastatin
NCT01929070A Pilot Study to Evaluate the Pharmacokinetics of Omega-3 Between Rosuvastatin and Omega-3 Coadministration and HCP1007
NCT01775579Evaluating a Pharmacokinetic Drug Interaction Between Metformin Hydrochloride and Rosuvastatin Calcium
NCT01929512Comparison of PK After Administration of HCP1201 and Co-administration of Metformin SR 750mg and Rosuvastatin 20mg
NCT02011633Comparison of PK After Administration of HCP1201 and Co-administration of Metformin SR 500mg and Rosuvastatin 10mg
NCT02026817Comparison of PK After Administration of HCP1201 and Co-administration of Metformin SR 750mg and Rosuvastatin 10mg